GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

EME · Dec 31, 2022

EMCOR Group, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000105634-23-000005General Corporate
Capex intensity45thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.45% · OPTIONAL · VALID

Operating cash generation60thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

4.50% · OPTIONAL · VALID

Revenue growth60thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

11.84% · CORE · VALID

Gross margin20thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

14.48% · CORE · VALID

Operating margin60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

5.10% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History41 statesSelf-history eligible
Period transition

What moved in the state?

Capex Intensity Increased
Previous
0.39%
Current
0.45%
Delta
0.06%
Cash Generation Decreased
Previous
9.10%
Current
4.50%
Delta
-4.60%
Growth Decreased
Previous
12.08%
Current
11.84%
Delta
-0.24%
Margin Decreased
Previous
14.62%
Current
14.48%
Delta
-0.14%
Profitability Decreased
Previous
5.31%
Current
5.10%
Delta
-0.21%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.